Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogens | 7 | 2009 | 194 | 1.160 |
Why?
|
| Estrogen Replacement Therapy | 5 | 2009 | 216 | 0.720 |
Why?
|
| Cognition | 3 | 2009 | 547 | 0.620 |
Why?
|
| Menopause | 2 | 2009 | 109 | 0.560 |
Why?
|
| Ovariectomy | 8 | 2009 | 202 | 0.540 |
Why?
|
| Attention | 3 | 2009 | 84 | 0.520 |
Why?
|
| Neurons | 4 | 2009 | 486 | 0.420 |
Why?
|
| Brain | 5 | 2012 | 966 | 0.400 |
Why?
|
| Primates | 1 | 2014 | 128 | 0.400 |
Why?
|
| Macaca fascicularis | 6 | 2009 | 542 | 0.370 |
Why?
|
| Progesterone | 3 | 2009 | 78 | 0.360 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 2 | 2009 | 4 | 0.340 |
Why?
|
| Models, Animal | 2 | 2009 | 188 | 0.340 |
Why?
|
| Caloric Restriction | 4 | 2012 | 92 | 0.320 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1081 | 0.310 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 32 | 0.300 |
Why?
|
| Synapses | 1 | 2009 | 87 | 0.280 |
Why?
|
| Basal Nucleus of Meynert | 2 | 2009 | 5 | 0.280 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2009 | 157 | 0.270 |
Why?
|
| Acetylcholine | 2 | 2005 | 69 | 0.270 |
Why?
|
| Animals | 14 | 2014 | 8196 | 0.270 |
Why?
|
| Postmenopause | 2 | 2007 | 424 | 0.250 |
Why?
|
| Cultural Diversity | 1 | 2006 | 17 | 0.240 |
Why?
|
| Mentors | 1 | 2006 | 33 | 0.240 |
Why?
|
| Schools, Medical | 1 | 2006 | 43 | 0.240 |
Why?
|
| Space Perception | 2 | 2005 | 30 | 0.240 |
Why?
|
| Minority Groups | 1 | 2006 | 81 | 0.240 |
Why?
|
| Faculty, Medical | 1 | 2006 | 76 | 0.230 |
Why?
|
| Parietal Lobe | 2 | 2010 | 15 | 0.230 |
Why?
|
| Students, Medical | 1 | 2006 | 126 | 0.220 |
Why?
|
| Vesicular Transport Proteins | 1 | 2004 | 12 | 0.210 |
Why?
|
| Cholinergic Fibers | 1 | 2004 | 10 | 0.210 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 39 | 0.200 |
Why?
|
| Prefrontal Cortex | 1 | 2004 | 86 | 0.200 |
Why?
|
| Age Factors | 4 | 2010 | 1178 | 0.190 |
Why?
|
| Aging | 5 | 2012 | 942 | 0.190 |
Why?
|
| Scopolamine | 1 | 2002 | 8 | 0.180 |
Why?
|
| Choline | 1 | 2002 | 18 | 0.180 |
Why?
|
| Muscarinic Antagonists | 1 | 2002 | 38 | 0.180 |
Why?
|
| Brain Mapping | 3 | 2012 | 190 | 0.170 |
Why?
|
| Visual Perception | 1 | 2002 | 121 | 0.170 |
Why?
|
| Iron | 2 | 2012 | 94 | 0.170 |
Why?
|
| Psychomotor Performance | 2 | 2012 | 108 | 0.160 |
Why?
|
| Female | 13 | 2012 | 19935 | 0.150 |
Why?
|
| Macaca mulatta | 5 | 2012 | 340 | 0.140 |
Why?
|
| Analysis of Variance | 3 | 2010 | 471 | 0.130 |
Why?
|
| Haplorhini | 2 | 2009 | 75 | 0.130 |
Why?
|
| Cell Count | 2 | 2009 | 51 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 544 | 0.110 |
Why?
|
| Animal Experimentation | 1 | 2014 | 6 | 0.110 |
Why?
|
| Hypothalamus | 2 | 2004 | 22 | 0.100 |
Why?
|
| Glucose | 1 | 2012 | 160 | 0.080 |
Why?
|
| Homocysteine | 1 | 2010 | 16 | 0.080 |
Why?
|
| Pituitary Gland, Posterior | 2 | 2007 | 2 | 0.080 |
Why?
|
| Movement | 1 | 2010 | 61 | 0.080 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2009 | 6 | 0.080 |
Why?
|
| Humans | 7 | 2014 | 32262 | 0.080 |
Why?
|
| Diagonal Band of Broca | 1 | 2009 | 2 | 0.070 |
Why?
|
| Septal Nuclei | 1 | 2009 | 16 | 0.070 |
Why?
|
| Cell Size | 1 | 2009 | 40 | 0.070 |
Why?
|
| Photic Stimulation | 1 | 2009 | 167 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 292 | 0.070 |
Why?
|
| Estradiol | 1 | 2009 | 139 | 0.070 |
Why?
|
| Motor Activity | 1 | 2010 | 332 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 64 | 0.060 |
Why?
|
| Nebraska | 1 | 2006 | 6 | 0.060 |
Why?
|
| Leadership | 1 | 2006 | 45 | 0.060 |
Why?
|
| Education, Medical | 1 | 2006 | 69 | 0.060 |
Why?
|
| United States | 1 | 2014 | 4068 | 0.060 |
Why?
|
| Neuropeptide Y | 1 | 2004 | 2 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2004 | 5 | 0.050 |
Why?
|
| Time | 1 | 2004 | 27 | 0.050 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2003 | 9 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2004 | 145 | 0.050 |
Why?
|
| North Carolina | 1 | 2006 | 1300 | 0.050 |
Why?
|
| Male | 5 | 2012 | 19429 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2012 | 1211 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 232 | 0.040 |
Why?
|
| Time Factors | 1 | 2005 | 2203 | 0.040 |
Why?
|
| Gene Expression | 2 | 2007 | 346 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2007 | 499 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2012 | 99 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 77 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 650 | 0.020 |
Why?
|
| Red Nucleus | 1 | 2010 | 2 | 0.020 |
Why?
|
| Atrophy | 1 | 2010 | 46 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2010 | 25 | 0.020 |
Why?
|
| Globus Pallidus | 1 | 2010 | 9 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 2010 | 20 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 2010 | 23 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2010 | 34 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 359 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 390 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 727 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2007 | 3893 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 11 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2007 | 33 | 0.020 |
Why?
|
| Adult | 2 | 2007 | 9252 | 0.010 |
Why?
|
| Species Specificity | 1 | 2003 | 98 | 0.010 |
Why?
|
| Aged | 2 | 2007 | 10249 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2003 | 69 | 0.010 |
Why?
|
| Amygdala | 1 | 2003 | 60 | 0.010 |
Why?
|
| Cell Movement | 1 | 2003 | 167 | 0.010 |
Why?
|
| Middle Aged | 2 | 2007 | 11837 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 478 | 0.010 |
Why?
|